Aducanumab: A Deep Dive into BIIB037 and its Impact The compound, originally known as BIIB037, represents a notable endeavor to address early-stage Alzheimer's condition. Designed by Biogen, aducanumab functions by https://www.targetmol.com/compound/aducanumab